Publications

Journal Article Epublish 50 citations
Electronic publication date
July 11, 2020

View on Pubmed.gov 32647796 | View on doi.org 10.1097/HS9.000...

Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia.

Search for publications in this journal Hemasphere - 4(3):e371

Abstract

Myeloproliferative neoplasms (MPNs) are characterized by deregulation of mature blood cell production and increased risk of myelofibrosis (MF) and leukemic transformation. Numerous driver mutations have been identified but substantial disease heterogeneity remains unexplained, implying the involvement of additional as yet unidentified factors. The inflammatory microenvironment has recently attracted attention as a crucial factor in MPN biology, in particular whether inflammatory cytokines and chemokines contribute to disease establishment or progression. Here we present a large-scale study of serum cytokine profiles in more than 400 MPN patients and identify an essential thrombocythemia (ET)-specific inflammatory cytokine signature consisting of Eotaxin, GRO-α, and EGF. Levels of 2 of these markers (GRO-α and EGF) in ET patients were associated with disease transformation in initial sample collection (GRO-α) or longitudinal sampling (EGF). In ET patients with extensive genomic profiling data (n = 183) cytokine levels added significant prognostic value for predicting transformation from ET to MF. Furthermore, CD56 +CD14 + pro-inflammatory monocytes were identified as a novel source of increased GRO-α levels. These data implicate the immune cell microenvironment as a significant player in ET disease evolution and illustrate the utility of cytokines as potential biomarkers for reaching beyond genomic classification for disease stratification and monitoring.

References

Blood Cancer J. 2018 Feb 9;8(2):15

J Clin Oncol. 2011 Apr 1;29(10):1356-63

Int J Mol Sci. 2016 Jul 05;17(7):

Blood. 2012 Aug 16;120(7):1409-11

Cited by 50 citations (total)

Journal Article Review

Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR-ABL-Negative Myeloproliferative Neoplasm.

Electronic publication date October 30, 2020

Search for publications in this journal Antioxidants (Basel)

Alessandro Allegra [...] Sebastiano Gangemi et al.

Philadelphia-negative chronic myeloproliferative neoplasms (MPNs) have recently been revealed to be related to chronic inflammation, oxidative stress, and the accumulation...

Journal Article Review

The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: "Crafting" a Microenvironment That Matters.

Electronic publication date November 17, 2021

Search for publications in this journal Cells

Lucia Catani [...] Francesca Palandri et al.

Myeloproliferative Neoplasms (MPN) are acquired clonal disorders of the hematopoietic stem cells and include Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis....

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Copyright

Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.